Hepatitis C virus antibodies among risk groups in Spain.
about
Clinical significance of hepatitis C virus genotypesAlcoholic liver disease and hepatitis C virus infectionAdvances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature ReviewNon-A, non-B hepatitis.Hepatitis C virus. A review.Seroepidemiology of viral infections among intravenous drug users in northern California.The native form and maturation process of hepatitis C virus core proteinHighly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.Immunological abnormalities and hepatotropic viral infectionsSexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIVHepatitis C virus: evidence for sexual transmissionClinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infectionClinical guidelines on the management of hepatitis CPrevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patientsThe elusive hepatitis C virusUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionPreclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNADynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantationPrevalence of antibodies to hepatitis C virus after blood transfusion in heart surgeryHepatologyExpression of processed core protein of hepatitis C virus in mammalian cellsHepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distributionInvestigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassayClinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infectionSerological markers of posttransfusion hepatitis C viral infectionDetection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reactionMapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3Hepatitis C markers in hemodialysis patientsVirological features of hepatitis C virus infection in hemodialysis patientsAnalysis of discordant test results among five second-generation assays for anti-hepatitis C virus antibodies also tested by polymerase chain reaction-RNA assay and other laboratory and clinical tests for hepatitisChronic hepatitis C: the virus, its discovery and the natural history of the disease.Treatment of autoimmune hepatitis.Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.Human immunodeficiency virus (HIV) infection, sexually transmitted diseases and HIV-antibody testing practices in Belgian prostitutes.Sexually transmitted hepatitis: a review.Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.Clinical sequelae of hepatitis C acquired from injection drug use.Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs.
P2860
Q24514512-A565FD0B-AE49-4755-88B8-AFF00076ACDEQ26773274-93FD8761-E232-43CD-8DC3-02C1B5D585AFQ26824039-76D83EFE-110F-4D29-89FD-E40B7D1B46A0Q27469293-DB3E1E6A-1D8F-4620-B650-A90DCB5B6073Q27469295-EEBB61EB-4FD2-457A-AFCD-6E75B510527DQ27469296-8315584D-A976-4258-8CE5-A341A6353C99Q27469583-649E4DB7-AB65-4C9E-8894-CEF2E6EF2B5DQ27471239-9FE2CD6C-06E1-4255-A815-17C8978C0875Q27472999-49650726-53FC-450C-AF5C-6C30809E0711Q27473006-7C07EAE8-B012-47F5-A2F3-C820A3F988ACQ27473546-9110DBE7-D09E-420A-A187-4C30F0A22B16Q27477689-4C044ABF-6B76-4387-8BAE-FC5D25FD48D4Q27477698-02BD99AF-88E7-4731-B4D2-E44FEB865ACFQ27477830-A03C2F0C-FDFE-43E7-B370-F540ADAADF34Q27477946-1DF7D057-6278-424E-B384-04550626053BQ27477958-2481AF0F-241D-400C-82E2-28CA34719433Q27478191-EB4DA785-56D8-4A60-A676-9EEC2F827163Q27480326-D82FE672-E7BA-4E1A-9261-5D07002D3B51Q27485655-3CD18597-63EE-4BA7-80EA-826F78A29550Q27485985-FE87DD0D-2828-408B-838A-564CD8C2134DQ27486160-E85CF1EB-627C-420C-93AE-6E465DB40AE7Q27486176-AF7FD4F2-8FEE-455A-9401-F94B0D6082ABQ27486227-FE55AC54-A935-4F70-894E-2AA32DE95060Q27486234-3C2C3B17-7C38-4D5D-B289-90BF6D1AAB19Q27487574-5E16E7C0-CA5B-4B00-8F71-CAC3C05B419AQ27487934-5DC577C2-5A63-4957-AF0A-830AFD82A8A2Q27487982-B4F7270A-2969-43A0-9DA8-0F3D3D46F185Q27488101-7271C7CE-E68B-4837-9F02-C842AED2F720Q27488210-9C85B37C-DF24-474B-A9BE-8D2EB730820FQ27488215-E7849AEF-C8AA-4287-95AB-64B016100F0EQ27488263-A275CEC4-564E-4DE7-8965-6289A2F2ACADQ27488264-26828D6E-64BC-483D-AF6B-AAF7C3E32CD6Q30431528-EFF8D0B4-284A-4C5B-9F0A-AA35EF19EA3DQ33618244-D93DFEB4-E717-4F4C-9C03-A580DD25D16EQ33703485-CE1C6BD5-D1D8-43D3-A8DF-DA2991535CFAQ33932782-7E62C7F8-FF54-452B-8BF4-474FFD218BD1Q33933564-A037BE54-EE38-4AEA-9B2B-43DC8AF4C509Q33954084-2B062E93-114E-4E91-A30D-A7D9644D7BBFQ34183346-6593C055-86F8-41DE-9870-7CC93C505C8CQ34210001-484525EF-169C-4768-A9AA-C4C528E2C295
P2860
Hepatitis C virus antibodies among risk groups in Spain.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Hepatitis C virus antibodies among risk groups in Spain.
@en
Hepatitis C virus antibodies among risk groups in Spain.
@nl
type
label
Hepatitis C virus antibodies among risk groups in Spain.
@en
Hepatitis C virus antibodies among risk groups in Spain.
@nl
prefLabel
Hepatitis C virus antibodies among risk groups in Spain.
@en
Hepatitis C virus antibodies among risk groups in Spain.
@nl
P2093
P1433
P1476
Hepatitis C virus antibodies among risk groups in Spain.
@en
P2093
A González
J C López-Talavera
J I Esteban
J M Hernández
L Viladomiu
P304
P356
10.1016/S0140-6736(89)90485-6
P407
P577
1989-08-01T00:00:00Z